In 2010 the first clinical trial of CAR-T therapy was reported

In 2010 the first clinical trial of CAR-T therapy was reported, using second-gen CARs and targeted at CD19 in non-Hodkin’s lymphoma, a blood cancer. CD19 is still the predominant CAR-T cell target under investigation.

2018-09-07T16:03:43+09:30September 7th, 2010|timeline|